KD Logo

Investing in Idexx Laboratories, Inc. (IDXX) Is Getting More Attractive

In a filing, Idexx Laboratories, Inc. revealed its Director Claflin Bruce L. unloaded Company’s shares for reported $0.11 million on May 17 ’24. In the deal valued at $540.80 per share,200 shares were sold. As a result of this transaction, Claflin Bruce L. now holds 161 shares worth roughly $76834.03.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Then, POLEWACZYK JAMES F sold 8,104 shares, generating $4,525,596 in total proceeds. Upon selling the shares at $558.44, the Executive Vice President now owns 10,711 shares.

Before that, Vandebroek Sophie V. sold 1,404 shares. Idexx Laboratories, Inc. shares valued at $790,427 were divested by the Director at a price of $562.98 per share. As a result of the transaction, Vandebroek Sophie V. now holds 1,216 shares, worth roughly $0.58 million.

Piper Sandler downgraded its Idexx Laboratories, Inc. [IDXX] rating to a Neutral from a an Overweight in a research note published recently. A number of analysts have revised their coverage, including Exane BNP Paribas’s analysts, who began to cover the stock in early December with a ‘”an Outperform”‘ rating. Cleveland Research also remained covering IDXX and has increased its forecast on December 04, 2023 with a “Buy” recommendation from previously “Neutral” rating. Atlantic Equities revised its rating on August 02, 2023. It rated IDXX as “a Neutral” which previously was an “an Overweight”.

Price Performance Review of IDXX

On Tuesday, Idexx Laboratories, Inc. [NASDAQ:IDXX] saw its stock jump 0.17% to $477.23. Over the last five days, the stock has lost -2.82%. Idexx Laboratories, Inc. shares have fallen nearly -14.02% since the year began. Nevertheless, the stocks have fallen -4.98% over the past one year. While a 52-week high of $583.39 was reached on 03/01/24, a 52-week low of $372.50 was recorded on 05/01/24. SMA at 50 days reached $500.25, while 200 days put it at $501.81. A total of 0.41 million shares were traded, compared to the trading of 0.86 million shares in the previous session.

Levels Of Support And Resistance For IDXX Stock

The 24-hour chart illustrates a support level at 473.27, which if violated will result in even more drops to 469.32. On the upside, there is a resistance level at 481.00. A further resistance level may holdings at 484.77. The Relative Strength Index (RSI) on the 14-day chart is 34.28, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -14.72, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 91.44%. Stochastics%K at 6.30% indicates the stock is a buying.

Most Popular